ADMA Biologics, Inc. (ADMA)

ADMA Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	71.63	103.15	51.35	86.52	51.09	55.92
Cash & Short-Term Investments	71.63	103.15	51.35	86.52	51.09	55.92
Cash Growth	58.03%	100.86%	-40.65%	69.36%	-8.64%	109.03%
Receivables	99.41	50	27.42	15.51	28.58	13.24
Inventory	172.19	170.24	172.91	163.28	124.72	81.54
Prepaid Expenses	8.59	8.03	5.33	5.1	4.34	3.05
Total Current Assets	351.81	331.41	257.01	270.4	208.73	153.74
Property, Plant & Equipment	65.73	63.34	63.47	68.75	58.2	45.85
Goodwill	3.53	3.53	3.53	3.53	3.53	3.53
Other Intangible Assets	0.45	0.46	0.5	1.01	1.73	2.44
Long-Term Deferred Tax Assets	80.86	84.28	-	-	-	-
Other Long-Term Assets	8.19	5.66	4.67	4.77	4.07	2.11
Total Assets	510.57	488.68	329.18	348.46	276.25	207.67
Accounts Payable	20.61	20.22	15.66	13.23	12.43	11.07
Accrued Expenses	22.91	28.63	30.55	23.19	16.23	8.16
Current Portion of Leases	1.19	1.22	1.05	0.91	0.59	0.37
Current Income Taxes Payable	6.6	3.48	-	-	-	-
Current Unearned Revenue	0.14	0.14	0.18	0.14	0.14	0.14
Other Current Liabilities	2.05	1.85	2.37	1.8	0.98	0.21
Total Current Liabilities	53.5	55.54	49.81	39.27	30.38	19.95
Long-Term Debt	72.53	72.34	130.59	142.83	94.87	92.97
Long-Term Leases	8.3	8.56	9.78	10.7	7.46	4.33
Long-Term Unearned Revenue	1.51	1.55	1.69	1.83	1.98	2.12
Other Long-Term Liabilities	1.32	1.67	2.11	1.85	0.4	0.05
Total Liabilities	137.15	139.66	193.98	196.49	135.08	119.42
Common Stock	0.02	0.02	0.02	0.02	0.02	0.01
Additional Paid-In Capital	655.07	657.58	641.44	629.97	553.27	428.7
Retained Earnings	-281.68	-308.58	-506.26	-478.02	-412.11	-340.47
Shareholders' Equity	373.42	349.02	135.21	151.97	141.17	88.25
Total Liabilities & Equity	510.57	488.68	329.18	348.46	276.25	207.67
Total Debt	82.01	82.12	141.42	154.44	102.92	97.67
Net Cash (Debt)	-10.39	21.03	-90.07	-67.92	-51.83	-41.75
Net Cash Per Share	-0.04	0.09	-0.40	-0.34	-0.37	-0.48
Filing Date Shares Outstanding	238.73	237.62	228.22	222.16	195.92	121.28
Total Common Shares Outstanding	238.53	236.62	226.06	221.82	195.81	104.9
Working Capital	298.32	275.87	207.21	231.14	178.35	133.79
Book Value Per Share	1.57	1.48	0.60	0.69	0.72	0.84
Tangible Book Value	369.44	345.03	131.18	147.43	135.91	82.28
Tangible Book Value Per Share	1.55	1.46	0.58	0.66	0.69	0.78
Land	4.34	4.34	4.34	4.34	4.34	4.34
Buildings	22.54	21.79	20.22	19.54	19.07	17.4
Machinery	34	32.92	32.93	29.2	24.17	20.11
Construction In Progress	11.23	8.15	2.27	6.73	5.5	3.34
Leasehold Improvements	21.1	21.07	20.81	17.93	11.13	5.27

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q